Therapeutic efficacy of GM-CSF in pulmonary alveolar proteinosis;Eficacia terapéutica del GM-CSF en la proteinosis alveolar pulmonar

Archivos de Bronconeumologia

Volumn 38, Issue 4, 2002, Pages 191-193

  Acosta, O ^a   Maranes I ^a   Perez A ^a   Hernandez A I ^a   Bello, M D ^a   Lopez Y ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

GM CSF; Pulmonary alveolar proteinosis; Whole pulmonary lavage

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; ENDOBRONCHIAL INTUBATION; ENDOTRACHEAL INTUBATION; GENERAL ANESTHESIA; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG FUNCTION; LUNG LAVAGE; MALE; PATHOGENESIS; THORAX RADIOGRAPHY;

EID: 2142702804     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(02)75188-0     Document Type: Article

References (6)

1. Miller RR, Churg AM, Hutcheon M, et al. Pulmonary alveolar proteinosis and aluminium dust exposure. Am Rev Respir Dis 1984;130:312-5.
2. Keller CA, Frost A, Cagle PT, et al. Pulmonary proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest 1995;108:277-80.
3. Carraway MS, Ghio AJ, Carter JD, Piantadisi CA. Detection of GM-CSF in patients with Pulmonary Alveolar Proteinosis. Am J Respir Crit Care Med 2000;161:1294-9.
4. Seymour JF, Begley CG, Dirksen U, Presneill JJ, Nicola A, Moore PE, et al. Attenuated hematopoietic response to GM-CSF in patients with Acquired pulmonary alveolar proteinosis. Blood 1998;92:2657-67.
5. Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle AR, et al. Therapeutic efficacy of GM-CSF in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001;163:524-31.
6. Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoinmune disease with neutralizing antibody against GM-CSF. Jexp Med 1999;190:875-80.